$0.33
arrow_drop_down1.40%Key Stats | |
---|---|
Open | $0.35 |
Prev. Close | $0.33 |
EPS | -1.31 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $172.65M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.33 | 0.36 |
52 Week Range | 0.29 | 1.09 |
Ratios | |
---|---|
Revenue | - |
EPS | -1.31 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant
23andMe Launches New Genetic Report on Bipolar Disorder
Why 23andMe Stock Tumbled 10% on Tuesday